MillerKnoll (MLKN) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
20 Jan, 2026Executive summary
Entered fiscal 2025 with momentum as orders increased 2.4% year-over-year (3.5% organically), led by Americas Contract and International Contract & Specialty segments.
Net sales for Q1 FY25 declined 6.1% year-over-year to $861.5M; organic sales down 5.3%.
Gross margin held steady at 39.0%, supported by pricing actions and product mix; adjusted operating margin was 5.8%.
Adjusted diluted EPS was $0.36, down 2.7% from last year; reported diluted loss per share was $(0.02).
Backlog increased 9.2% year-over-year to $758.0M, up 10.9% since fiscal year start.
Financial highlights
Consolidated orders reached $936M, up 2.4% year-over-year (3.5% organically).
Operating earnings fell 62.3% to $15.2M; net loss attributable to MillerKnoll was $1.2M.
Cash flow from operations was $21.1M; $43.7M spent on share repurchases.
Cash and cash equivalents at quarter-end were $209.7M; total liquidity was $488.4M.
Net debt to EBITDA ratio at 2.84x at quarter end.
Outlook and guidance
Maintaining full-year adjusted EPS guidance of $2.20, supported by order growth and backlog.
Q2 FY25 net sales expected between $950M and $990M; adjusted diluted EPS between $0.51 and $0.57.
Shift in retail promotional period will move $17M–$23M of revenue from Q2 to Q3.
Full-year capital expenditures projected at $100M–$125M.
Company believes current liquidity and cash flow are sufficient for near-term operations and capital needs.
Latest events from MillerKnoll
- Q3 FY2026 delivered sales growth, margin gains, and strong order momentum despite global risks.MLKN
Q3 202625 Mar 2026 - Margins and EPS rose in Q4 despite lower sales, with a strong outlook for FY2025.MLKN
Q4 20243 Feb 2026 - Q2 net sales up 2.2% to $970.4M, strong Americas growth, adjusted EPS $0.55, guidance narrowed.MLKN
Q2 202510 Jan 2026 - Orders rose 5.5% and gross margin hit 39.0%, offsetting a 1.6% sales decline.MLKN
Q2 20265 Jan 2026 - $130M impairment drove Q3 loss, but retail orders and guidance remain strong.MLKN
Q3 202526 Dec 2025 - Profitability improved, global reach expanded, and sustainability advanced; all proposals recommended for approval.MLKN
Proxy Filing1 Dec 2025 - Shareholders to vote on directors, executive pay, auditor, and new incentive plan amid growth focus.MLKN
Proxy Filing1 Dec 2025 - Key votes: director elections, executive pay, auditor ratification, and incentive plan approval.MLKN
Proxy Filing1 Dec 2025 - Key votes include director elections, executive pay approval, and auditor ratification.MLKN
Proxy Filing1 Dec 2025